Sponsors (4)
Introduced May 1, 2025 by Thomas Roland Tillis · Last progress May 1, 2025
The bill restores broader, clearer eligibility for many tangible inventions and lab-altered biotech (reducing filing uncertainty and protecting investment) while narrowing protection for pure business/mental processes and creating new ambiguities that could allow overbroad patents and spur litigation.
Inventors, researchers, and small businesses regain clearer, broader patent eligibility for processes, machines, manufactures, and compositions, reducing uncertainty when filing and enforcing patents.
Biotech and materials developers (labs and startups) can patent purified, isolated, or otherwise altered genes and natural materials, protecting investments in lab-altered products and enabling commercialization.
Researchers, inventors, and small companies gain clearer eligibility standards (including a statutory 'useful' definition) and rules limiting eligibility-focused discovery, which should reduce uncertainty in filings and speed resolution of some disputes.
Tech companies, software developers, and many startups lose the ability to patent economic, financial, business, social, cultural, or artistic processes, narrowing protection for software and business-method innovations.
Small businesses, tech firms, and consumers may face more litigation and higher costs because the Act removes certain judicial exceptions and directs eligibility decisions without regard to whether claim elements are conventional, which can allow low-quality or overbroad patents to issue.
Ambiguity over what counts as a 'purely mental' process or what is 'necessary to practically perform the invention' (vs. nonessential computer recitations) will generate litigation and inconsistent court interpretations, increasing uncertainty for inventors and practitioners.
Based on analysis of 4 sections of legislative text.
Clarifies and broadens statutory patent eligibility, lists specific exclusions (e.g., bare math, purely mental steps, unmodified genes/natural materials), and sets rules for when exclusions do not apply.
Clarifies and expands what can be patented by replacing current judicial eligibility tests with a statutory rule that restores broad patent eligibility for useful processes, machines, manufactures, and compositions, while listing explicit categories that remain ineligible. It narrows judicial exceptions, defines key terms, sets how eligibility must be assessed, and authorizes courts to decide eligibility in infringement cases with limited discovery. The law also specifies exclusions (purely mental steps; bare mathematical formulas; unmodified human genes and naturally occurring materials as found in nature; and purely human-performed business, social, cultural, or artistic processes), explains when excluded items can become eligible (e.g., when altered, purified, integrated in a machine/useful invention, or impossible to practicably perform without a machine), and preserves other patent doctrines such as novelty, nonobviousness, and obviousness-type double patenting.